Medicared For All Logo

Michael Bergeron in Lake Charles, Louisiana

Home Louisiana Lake Charles

Michael Bergeron has Medical Oncology as his primary medical specialty. Their primary office is: 2770 3rd Ave in Lake Charles, Louisiana.

They're a part of the: Swlhs Oncology, Inc. medical group which has around 5 members. You can call their office at 337-494-6768 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Louisiana State University School Of Medicine In New Orleans and graduated in 1992 (around 32 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Michael Bergeron Office Phone and Directions

Michael Bergeron
Swlhs Oncology, Inc.
2770 3rd Ave
Lake Charles, Louisiana 70601
337-494-6768


Patient Ratings
Please rate your experience with Michael Bergeron below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 337-494-6768


Enter a starting address:


Healthcare Info for Michael Bergeron

Medical School: Louisiana State University School Of Medicine In New Orleans
Graduation Year: 1992
The Primary Medical Specialty for Michael Bergeron is listed as: Medical Oncology
Approximate Years of Experience: 32
PAC (PECOS ID)#: 8022166909
NPI #: 1265558308
NPI Created On: 03/21/2007
NPI Last Updated Listed as: 07/24/2017
Primary Taxonomy Code: 207RH0003X
License Number:
MD25200
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 45 minutes
  2. New patient office or other outpatient visit, typically 60 minutes
  3. Established patient office or other outpatient visit, typically 15 minutes
  4. Established patient office or other outpatient, visit typically 25 minutes
  5. Initial hospital inpatient care, typically 50 minutes per day
  6. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $74

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051663

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051665

Being Disputed:: No

Product Related: No


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051667

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051675

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051679

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788051681

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Medical Oncology Professionals in Lake Charles

2770 3rd Ave
Lake-charles, LA
Swlhs Oncology, Inc.

2770 3rd Ave
Lake-charles, LA
Swlhs Oncology, Inc.

Providers in Swlhs Oncology, Inc.

1.Michael Bergeron

2770 3rd Ave
Lake Charles La 70601-8994
Swlhs Oncology, Inc.
Medical Oncology

2.Michael Broussard

2770 3rd Ave
Lake Charles La 70601-8994
Swlhs Oncology, Inc.
Medical Oncology

3.Leroy Fredericks

2770 3rd Ave
Lake Charles La 70601-8994
Swlhs Oncology, Inc.
Medical Oncology

4.Mohammad Khan Md

2770 3rd Ave
Lake Charles La 70601-8994
Swlhs Oncology, Inc.
Hematology/oncology

5.Lacey Vasilakis

2770 3rd Ave
Lake Charles La 70601-8994
Swlhs Oncology, Inc.
Nurse Practitioner

View all 5 members of Swlhs Oncology, Inc. medical group